Nav: Home

Current Hepatitis News and Events

Current Hepatitis News and Events, Hepatitis News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Kidneys infected with hepatitis C can be safely transplanted into healthy recipients
Kidneys infected with hepatitis C can be safely transplanted into healthy recipients (2020-09-02)
Premature deaths from alcoholic liver disease rising as gap between men and women narrows
A new study in the American Journal of Preventive Medicine identifies emerging patterns in the rate of and age at premature death from alcoholic (alcohol-associated) liver disease (ALD) in the US over the last two decades. (2020-08-27)
UofSC researchers reveal how THC may treat acute respiratory distress syndrome
Acute Respiratory Distress Syndrome (ARDS), when caused by a bacterial toxin known as Staphylococcal enterotoxin, can be completely prevented by treatment with Δ9-tetrahydrocannabinol (THC), a cannabinoid found in the cannabis plant. (2020-08-26)
Hepatitis B: Natural controllers shed light on immunity mechanisms
To improve our understanding of the antibody response conferring protection against HBV infection, scientists from the Institut Pasteur and Inserm, in collaboration with the Roche Innovation Center in Switzerland, produced and characterized human monoclonal antibodies specific to viral envelope antigens, referred as HBsAg, from blood memory B cells isolated from HBV vaccinees and natural controllers. (2020-08-13)
Busting Up the Infection Cycle of Hepatitis B
Researchers at the University of Delaware have gained new understanding of the virus that causes hepatitis B and the ''spiky ball'' that encloses its genetic blueprint. (2020-08-13)
Malaria discovery could expedite antiviral treatment for COVID-19
New research into malaria suggests targeting enzymes from the human host, rather than from the pathogen itself, could offer effective treatment for a range of infectious diseases, including COVID-19. (2020-08-11)
Strong link found between abnormal liver tests and poor COVID-19 outcomes
New Haven, Conn. -- Researchers at the Yale Liver Center found that patients with COVID-19 presented with abnormal liver tests at much higher rates than suggested by earlier studies. (2020-08-07)
SFU chemist's new process fast-tracks drug treatments for viral infections and cancer
Discovering antiviral and anticancer drugs will soon be faster and cheaper thanks to new research from Simon Fraser University chemist Robert Britton and his international team. (2020-08-07)
Unveiled: A channel SARS-CoV-2 may use to proceed with viral replication in the host cell
By visualizing coronavirus replication in an infected host cell, researchers may have answered a long-standing question about how newly synthesized coronavirus components are able to be incorporated into fully infectious viruses. (2020-08-06)
Stay or leave? A tale of two virus strategies revealed by math
By modeling experimentally measured characteristics of cells infected with hepatitis C in the lab, researchers in Japan found that one virus strain was roughly three times more likely to use copied genetic code to create new viruses compared to another, which instead tended to keep more copies inside an infected cell to accelerate replication. (2020-07-30)
Viral hepatitis: Europe needs to close the testing gap
Approximately four in five people living with hepatitis B and three out of four people with hepatitis C infection across the European Union and European Economic Area (EU/EEA) and the UK have not yet been diagnosed. (2020-07-27)
Closing the gap: finding undiagnosed hepatitis C infections after blood transfusions
What is the incidence of viral hepatitis caused by blood transfusions before and after Sweden introduced screening of blood in the early 1990s? (2020-07-23)
Pasteurizing breast milk inactivates SARS-CoV-2
Pasteurizing breast milk using a common technique inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) making it safe for use, according to new research in CMAJ (Canadian Medical Association Journal). ttps://www.cmaj.ca/content/cmaj/early/2020/07/09/cmaj.201309.full.pdf (2020-07-09)
Hepatitis C management at federally qualified health centers proves cost-effective
BOSTON- New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers (FQHC) improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective. (2020-07-08)
Researchers identify multiple molecules that shut down SARS-Cov-2 polymerase reaction
Researchers at Columbia Engineering and the University of Wisconsin-Madison have identified a library of molecules that shut down the SARS-CoV-2 polymerase reaction, a key step that establishes the potential of these molecules as lead compounds to be further modified for the development of COVID-19 therapeutics. (2020-06-30)
Study finds HCV-positive livers safe for transplantation; Patients cured afterward
UC researchers find similar results for positive outcomes when comparing patients receiving livers infected with hepatitis C to patients who receive livers without infection. (2020-06-22)
Virus co-opts immune protein to avoid antiviral defences
By discovering a trick the hepatitis C virus uses to evade the immune system, scientists have identified a new antiviral defence system that could be used to treat many virus infections, according to new research published today in eLife. (2020-06-16)
Researchers discover key player in hepatitis A virus infection
University of North Carolina School of Medicine researchers designed experiments using gene-editing tools to discover how molecules called gangliosides serve as de facto gatekeepers to allow the virus entry into liver cells and trigger disease. (2020-05-26)
Liver cancer: Awareness of hepatitis D must be raised
Scientists from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have studied the most serious consequence of chronic hepatitis: hepatocellular carcinoma. (2020-05-18)
Supercomputer simulations present potential active substances against coronavirus
Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. (2020-05-05)
Racial inequalities in liver cancer deaths soared after launch of hepatitis C drugs
Before and after the introduction of lifesaving drugs for hepatitis C, researchers found that from 1979 to 1998, racial inequalities in mortality from liver cancer in the US were declining. (2020-04-30)
New findings on hepatitis C in infants can lead to improved treatments
Only about 5% of the babies born to mothers with hepatitis C are themselves infected by the disease. (2020-04-27)
How the immune system reacts to hepatitis C viruses
The interferon-stimulated gene C19orf66 plays an important role in the defence against hepatitis C viruses. (2020-04-24)
New macrolactone database could aid drug discovery, research
Researchers have created a free-to-use database of 14,000 known macrolactones -- large molecules used in drug development -- which contains information about the molecular characteristics, chemical diversity and biological activities of this structural class. (2020-04-21)
Increased rate of infections may indicate a future cancer diagnosis
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis. (2020-04-17)
Large majority of Washington state's heroin users want to reduce use
A new survey of people who inject illicit drugs in the state of Washington yields positive and important findings for policy makers as the world struggles to deal with the COVID-19 pandemic. (2020-04-10)
New hepatitis C cases down by almost 70% in HIV positive men in London and Brighton
New cases of hepatitis C amongst HIV positive men in London and Brighton have fallen by nearly 70% in recent years. (2020-03-25)
Study uncovers increasing global rates of liver cancer
New research reveals rising rates of liver cancer around the world, despite advances aimed at preventing the disease. (2020-03-23)
Low-dose aspirin linked to reduced liver cancer risk
Among adults at high risk of liver cancer, those who took low-dose aspirin were less likely to develop the disease or to die from liver-related causes. (2020-03-12)
Princeton researchers identify factors essential for chronic hepatitis B infection
A study published in the journal Nature Microbiology identified factors that the hepatitis B virus uses when establishing long-term infection in the liver. (2020-03-09)
Liver fibrosis tied to specific heart failure, regardless of HIV or hepatitis C status
While there is an association between liver fibrosis and heart failure, the mechanisms for this association are currently unclear but may be of particular importance for people living with human immunodeficiency virus (HIV) and/or hepatitis C, both of which are chronic infections that affect the liver and heart. (2020-03-06)
OHSU-led evidence review shows new therapy for Hepatitis C is highly effective
New direct-acting antiviral therapies are highly effective at eliminating the Hepatitis C virus infection, according to a systematic evidence review by researchers at Oregon Health & Science University. (2020-03-02)
Intervention to help GPs identify and treat patients with hepatitis C found to be effective
The first UK clinical trial to increase the identification and treatment of hepatitis C (HCV) patients in primary care has been found to be effective, acceptable to staff and highly cost-effective for the NHS. (2020-02-26)
Big investment needed to eliminate Hep C in Pakistan could deliver huge health benefits
A large investment of at least US$3.9 billion needed to meet the World Health Organization's (WHO) target for the elimination of Hepatitis C virus (HCV) in Pakistan could deliver huge benefits in terms of lives saved and reduced ill health, according to University of Bristol led research published in The Lancet Global Health today [19 February]. (2020-02-19)
Kidney patients benefit using organs from Hepatitis C-infected donors
Kidney patients benefit by accepting kidneys from donors with hepatitis C, according to a University of Cincinnati physician-researcher. (2020-02-17)
Tennessee infants exposed to hepatitis C at birth often not tested for virus
Most Tennessee infants exposed to hepatitis C at birth are not later tested to see if they acquired the virus, according to a study by researchers at Monroe Carell Jr. (2020-02-14)
Hepatitis B: New therapeutic approach may help to cure chronic hepatitis B infection
Researchers at Helmholtz Zentrum München, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B. (2020-02-03)
Liver fibrosis 'off switch' discovered in mice
UC San Diego School of Medicine researchers identified several genetic switches, or transcription factors, that determine whether or not liver cells produce collagen -- providing a new therapeutic target for liver fibrosis. (2020-01-23)
Antiviral treatments inspire researchers to develop a new kind of cancer drug
An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice. (2020-01-22)
First robust cell culture model for the hepatitis E virus
A mutation switches the turbo on during virus replication. This is a blessing for research. (2020-01-13)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Debbie Millman: Designing Our Lives
From prehistoric cave art to today's social media feeds, to design is to be human. This hour, designer Debbie Millman guides us through a world made and remade–and helps us design our own paths.
Now Playing: Science for the People

#574 State of the Heart
This week we focus on heart disease, heart failure, what blood pressure is and why it's bad when it's high. Host Rachelle Saunders talks with physician, clinical researcher, and writer Haider Warraich about his book "State of the Heart: Exploring the History, Science, and Future of Cardiac Disease" and the ails of our hearts.
Now Playing: Radiolab

Insomnia Line
Coronasomnia is a not-so-surprising side-effect of the global pandemic. More and more of us are having trouble falling asleep. We wanted to find a way to get inside that nighttime world, to see why people are awake and what they are thinking about. So what'd Radiolab decide to do?  Open up the phone lines and talk to you. We created an insomnia hotline and on this week's experimental episode, we stayed up all night, taking hundreds of calls, spilling secrets, and at long last, watching the sunrise peek through.   This episode was produced by Lulu Miller with Rachael Cusick, Tracie Hunte, Tobin Low, Sarah Qari, Molly Webster, Pat Walters, Shima Oliaee, and Jonny Moens. Want more Radiolab in your life? Sign up for our newsletter! We share our latest favorites: articles, tv shows, funny Youtube videos, chocolate chip cookie recipes, and more. Support Radiolab by becoming a member today at Radiolab.org/donate.